@CheriLev Strongest outcome data for GLP-1a is in T2D. I would rather have a shorter life ED free but when pts don’t say that physicians advocate for meds with best outcomes. There need to be open conversations like cancer screening. https://t.co/oP73hJrVc
@ModeledBehavior "GLP-1 receptor agonists reduced all-cause mortality by 12%" https://t.co/betBzoquaF Does anyone know what that is translated to in years?
@femisapien_z Esse é um dos estudos mais completos https://t.co/mNQ2smLLC0
RT @StevenMBelknap: No. Due to research designs obscuring drug safety signals, published RCT reports are unreliable sources about drug tox…
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @MWeintraubMD: Source: https://t.co/Jg0boY1RrQ Also check out this lecture on GLP1 and stroke risk by Dr. Inzucchi: https://t.co/xHxXF…
RT @MWeintraubMD: Source: https://t.co/Jg0boY1RrQ Also check out this lecture on GLP1 and stroke risk by Dr. Inzucchi: https://t.co/xHxXF…
RT @MichaelAlbertMD: Meta-analyses of in-trial data do not associate GLP1RAs with adverse pancreatic events. https://t.co/29nxr3yas7 htt…
RT @MWeintraubMD: Source: https://t.co/Jg0boY1RrQ Also check out this lecture on GLP1 and stroke risk by Dr. Inzucchi: https://t.co/xHxXF…
In a recent meta-analysis there was a 17% reduction in fatal and non-fatal stroke #Semaglutide leads the pack with 35% reduced stroke risk in the SUSTAIN-6 trial مراجع الدراسات: https://t.co/7zFn1W6jCz https://t.co/18vqYp03EK https://t.co/B6a04XEJBc
Source: https://t.co/Jg0boY1RrQ Also check out this lecture on GLP1 and stroke risk by Dr. Inzucchi: https://t.co/xHxXF7dZjc
RT @MichaelAlbertMD: Meta-analyses of in-trial data do not associate GLP1RAs with adverse pancreatic events. https://t.co/29nxr3yas7 htt…
Meta-analyses of in-trial data do not associate GLP1RAs with adverse pancreatic events. https://t.co/29nxr3yas7 https://t.co/xg8W8pcDqP
@ukubuza Such as this meta-analysis on GLP1Ra outcomes. https://t.co/k2As9Vy67i
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
@med_indonews And this is a good review of glp-1 analogs in diabetes in randomised trial. Can’t remember if it’s in the appendices but there’s a specific and interesting table on risks. https://t.co/N3QozsYaVv
@FBosom ? Do you read the peer-reviewed medical and scientific literature? The literature has shown a significant reduction in the incidence of major cardiovascular events in patients with type 2 diabetes mellitus treated with certain Glp-1 agonists. https
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
هذا حسب آخر التوصيات والدراسات الى الآن أثبتت أمانها في الاستخدام تفضلوا المصدر للي طلبه وحاب يطّلع عليه في التغريدة فيه رابط الدراسة #فضفضة_طبيب #السمنة #السكري
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
I believe some of the new meds are helpful. I also believe we need to keep digging deeper & look at root causes of metabolic illness.
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: Check out Supplementary Appendix Figure 1 https://t.co/PsI1axDMCT and here https://t.co/poFOgZsRlP
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @gu_girl: Critically important point!
RT @DanielJDrucker: Check out Supplementary Appendix Figure 1 https://t.co/PsI1axDMCT and here https://t.co/poFOgZsRlP
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: Check out Supplementary Appendix Figure 1 https://t.co/PsI1axDMCT and here https://t.co/poFOgZsRlP
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
Critically important point!
RT @DanielJDrucker: Check out Supplementary Appendix Figure 1 https://t.co/PsI1axDMCT and here https://t.co/poFOgZsRlP
Check out Supplementary Appendix Figure 1 https://t.co/PsI1axDMCT and here https://t.co/poFOgZsRlP
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
@DanielJDrucker these so called experts are skilled in auto promotion and as they are unable to produce any medical data based on facts prefer to scare patients. The parasites of the system
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
Yeah, check your bias and help people decrease their risk for heart disease, stroke, diabetes, AFib, OSA, rather than continue on a fear of an obscure harm. #obesitysummit
RT @dr_hojele: 📝🔹 بعد أكثر من ١٨ عام من الدراسات بين علاقة أدوية GLP-1(أوزمبيك..ساكسندا ..وغيرها ) والتهاب البنكرياس تأتي نتيجه دراسة محك…
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @DrKarlNadolsky: All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
All the data available reveal no significant risk pancreatitis from GLP-1 at therapy but that notion remains
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: @DrCDav No #Thyroidcancer signal in GLP-1 RCTs/CVOTs (PTC/FTC) but a small signal in the real world. Would be fascinati…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
RT @DanielJDrucker: There are now hundreds of authoritative experts that opine daily on the risk of GLP-1 therapies, often scaring people a…
يوجد الآن المئات من الباحثين المعتمدين الذين يبحثون بشكل يومي عن مخاطر علاج GLP-1 وغالبا ما يخيفون الناس بشأن خطر التهاب البنكرياس نتيجة لإستعمال هذا العلاج ولكن بعد ١٨ عاما من إستعماله
Reassuring data!